Compositions and methods for treating or preventing ocular bacterial infections, or disorders associated with such infections, are disclosed. The compositions include rifalazil or rifalazil derivatives, and optionally include other antimicrobial agents and/or anti-inflammatory agents. The compositions can be used to treat bacterial infections and associated ocular disorders. Trachoma and bacterial conjunctivitis are representative bacterial disorders that can be treated.
